These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 181235)
1. [Development of new vaccines]. Penttinen K Duodecim; 1976; 92(12):643-6. PubMed ID: 181235 [No Abstract] [Full Text] [Related]
2. Prophylaxis of viral hepatitis: transfusion transmitted disease and the hepatitis B vaccine. Holland PV Prog Clin Biol Res; 1983; 143():357-67. PubMed ID: 6322200 [No Abstract] [Full Text] [Related]
3. Immunogenicity of HBeAg in the New York Blood Center hepatitis B vaccine. Vnek J; Hashimoto N; Prince AM Dev Biol Stand; 1983; 54():217-21. PubMed ID: 6228461 [TBL] [Abstract][Full Text] [Related]
4. Viral Hepatitis: a review. Neimark S; Rogers AI Am J Gastroenterol; 1982 Jun; 77(6):431-5. PubMed ID: 6283881 [No Abstract] [Full Text] [Related]
5. [Etiology, diagnosis and the prospects for vaccinal prevention hepatitis B]. Anan'ev VA Vestn Akad Med Nauk SSSR; 1983; (12):37-40. PubMed ID: 6229935 [No Abstract] [Full Text] [Related]
6. [Present status of vaccines in 1989]. Roussey M; Dabadie A Pediatrie; 1989; 44(9):691-8. PubMed ID: 2560159 [TBL] [Abstract][Full Text] [Related]
7. [Various forms of hepatitis]. Magyar I Orv Hetil; 1982 Mar; 123(10):579-82. PubMed ID: 6803215 [No Abstract] [Full Text] [Related]
8. Adenovirus vaccine strains genetically engineered to express HIV-1 or HBV antigens for use as live recombinant vaccines. Hung PP; Chanda PK; Natuk RJ; Mason BB; Chengalvala M; Bhat BM; Molnar-Kimber KL; Dheer SK; Morin JE; Mizutani S Nat Immun Cell Growth Regul; 1990; 9(3):160-4. PubMed ID: 2196459 [TBL] [Abstract][Full Text] [Related]
9. New approaches to hepatitis B vaccines. Gerin JL; Purcell RH Prog Clin Biol Res; 1983; 143():369-77. PubMed ID: 6230679 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B: nature of the virus and prospects for vaccine development. Zuckerman AJ Prog Liver Dis; 1976; 5():326-36. PubMed ID: 775545 [No Abstract] [Full Text] [Related]
11. The agents of human viral hepatitis, and control of the disease. Deinhardt F Prog Med Virol; 1984; 30():14-28. PubMed ID: 6087411 [No Abstract] [Full Text] [Related]
12. Development of oral microencapsulated forms for delivering viral vaccines. Nechaeva E Expert Rev Vaccines; 2002 Oct; 1(3):385-97. PubMed ID: 12901577 [TBL] [Abstract][Full Text] [Related]
13. [Experiences with active vaccination against hepatitis B]. Horak W; Leithner C; Kemenesi W; Pinggera W Wien Med Wochenschr; 1983 Feb; 133(3):85-6. PubMed ID: 6845738 [No Abstract] [Full Text] [Related]
16. What you should know about new and current viral vaccines. Weibel RE Mod Med Asia; 1978 Jun; 14(6):28-34. PubMed ID: 207966 [No Abstract] [Full Text] [Related]
17. [An inoculation against hepatitis B may become a reality in 1982]. Muller-Christiansen K Zahnarztl Mitt; 1982 May; 72(9):1000-2. PubMed ID: 6956133 [No Abstract] [Full Text] [Related]
18. [Current problems in virus hepatitis]. Busse HJ Z Gesamte Inn Med; 1978 Jul; 33(13):417-22. PubMed ID: 581246 [No Abstract] [Full Text] [Related]
19. [A high-risk professional disease for dentists viral hepatitis B]. Matysiak M Actual Odontostomatol (Paris); 1983 Sep; (143):497-514. PubMed ID: 6660088 [No Abstract] [Full Text] [Related]
20. [Hepatitis B: epidemiology and state of prevention]. Frösner G; Zuckerman A Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():51-63. PubMed ID: 800914 [No Abstract] [Full Text] [Related] [Next] [New Search]